JESSICA CALABRO: Open Payments
NPI 1841880234 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 17 payments from 6 companies in 2025. Trend: 2023 $692 · 2024 $712 · 2025 $611
Food & beverage: $512Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $298 |
| Janssen Biotech, Inc. | 5 | $163 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Phathom Pharmaceuticals, Inc. | 4 | $39 |
| QOL Medical, LLC | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: TREMFYA, RINVOQ, SKYRIZI, MAVYRET, DUPIXENT, VOQUEZNA, Sucraid, ENTYVIO.
Industry payments across GA — which companies pay providers there.
